The purpose of this project was to develop business rules and composite score logic for evaluating the performance of organizations providing the Medicare Part D Drug Benefit. IMPAQ conducted analyses to support the Centers for Medicare & Medicaid Services (CMS) with decisions on performance star rating measures, display measures, compliance threshold, and other factors.
Our work helps organizations improve their performance and develop plan-specific quality improvement strategies. It also helps CMS more accurately reflect the performance of the Part D plans and support their policy and operational changes in the Star Ratings program.
We collected data and used quantitative analysis methods. Our techniques included univariate, bivariate, and multivariate statistical analyses; trend analysis; weighting methods; order statistics including nonparametrics and ranking order methodology; and statistical outlier analyses.
Our team included health economists, pharmacoepidemiologists, seasoned SAS programmers, health IT specialists, and research analysts with experience and capacity in CMS methodology and application of statistical quality and performance measurement. They combined their decades of experience in quantitative and qualitative research methods and statistics and economic modeling with their health policy experience.